EUVIMEDEUVIMED entdecken
Open Access

Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis

Yesh Datar, Olivier F Clerc iD, Sarah A M Cuddy, Sirwoo Kim, Alexandra Taylor, Jocelyn Canseco Neri, Dominik C Benz, Giada Bianchi, Andrew J Yee, Vaishali Sanchorawala, Frederick L Ruberg, Heather Landau und 7 weitere

European Heart Journal - Cardiovascular Imaging · 2024

DOI: 10.1093/ehjci/jead350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2024. Verfasst von Yesh Datar und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Ethylene Glycols, Aniline Compounds, Ventricular Dysfunction, Right. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In systemic light-chain (AL) amyloidosis, quantification of right ventricular (RV) amyloid burden has been limited and the pathogenesis of RV dysfunction is poorly understood. Using 18F-florbetapir positron emission tomography/computed tomography (PET/CT), we aimed to quantify RV amyloid; correlate RV amyloid with RV structure and function; determine the independent contributions of RV, left ventricular (LV), and lung amyloid to RV function; and associate RV amyloid with major adverse cardiac events (MACE: death, heart failure hospitalization, cardiac transplantation). Methods and results We prospectively enrolled 106 participants with AL amyloidosis (median age 62 years, 55% males) who underwent 18F-florbetapir PET/CT, magnetic resonance imaging, and echocardiography. 18F-florbetapir PET/CT identified RV amyloid in 63% of those with and 40% of those without cardiac involvement by conventional criteria. RV amyloid burden correlated with RV ejection fraction (EF), RV free wall longitudinal strain (FWLS), RV wall thickness, RV mass index, N-terminal pro-brain natriuretic peptide, troponin T, LV amyloid, and lung amyloid (each P < 0.001). In multivariable analysis, RV amyloid burden, but not LV or lung amyloid burden, predicted RV dysfunction (EF P = 0.014; FWLS P < 0.001). During a median follow-up of 28 months, RV amyloid burden predicted MACE (P < 0.001).

Conclusion

This study shows for the first time that 18F-florbetapir PET/CT identifies early RV amyloid in systemic AL amyloidosis prior to alterations in RV structure and function. Increasing RV amyloid on 18F-florbetapir PET/CT is associated with worse RV structure and function, predicts RV dysfunction, and predicts MACE. These results imply a central role for RV amyloid in the pathogenesis of RV dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyEthylene GlycolsAniline CompoundsVentricular Dysfunction, RightHumansMaleFemaleMiddle AgedProspective StudiesAgedImmunoglobulin Light-chain AmyloidosisRadiopharmaceuticalsHeart Ventricles

Stichwörter der Autor:innen

18F-florbetapircardiac magnetic resonance imagingechocardiographymajor adverse cardiac eventspositron emission tomographyright ventricular functionsystemic AL amyloidosis

Substanzen

Ethylene GlycolsflorbetapirAniline CompoundsRadiopharmaceuticals

Autor:innen und Institutionen

  • Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
  • Division of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
  • CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
  • Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Section of Hematology, Department of Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

ORCID-Profile: Olivier F Clerc, Sharmila Dorbala

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Datar, Y., Clerc, O. F., Cuddy, S. A. M., Kim, S., Taylor, A., Neri, J. C., Benz, D. C., Bianchi, G., Yee, A. J., Sanchorawala, V., Ruberg, F. L., Landau, H., Liao, R., Kijewski, M. F., Jerosch-Herold, M., Kwong, R. Y., Di Carli, M. F., Falk, R. H., & Dorbala, S. (2024). Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead350

Vancouver

Datar Y, Clerc OF, Cuddy SAM, Kim S, Taylor A, Neri JC, et al. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis. European Heart Journal - Cardiovascular Imaging. 2024. doi:10.1093/ehjci/jead350

BibTeX
@article{Datar2024,
  author = {Datar, Yesh and Clerc, Olivier F and Cuddy, Sarah A M and Kim, Sirwoo and Taylor, Alexandra and Neri, Jocelyn Canseco and Benz, Dominik C and Bianchi, Giada and Yee, Andrew J and Sanchorawala, Vaishali and Ruberg, Frederick L and Landau, Heather and Liao, Ronglih and Kijewski, Marie Foley and Jerosch-Herold, Michael and Kwong, Raymond Y and Di Carli, Marcelo F and Falk, Rodney H and Dorbala, Sharmila},
  title = {Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2024},
  doi = {10.1093/ehjci/jead350}
}
Kostenlos starten →